Persons
Webseiten-Inhalte
Detailsite | MedUni Vienna
...All News An international team of researchers, including Lukas Kenner from the Clinical Department of Pathology at MedUni Vienna, has discovered a specific combination of mutations and new gene fusions, which are heavily implicated in tumour growth in patients with a particularly...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=2862&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=6a2d709801f85c61eac73d68cbc1a9d3
Detailsite | MedUni Vienna
...All News An international team of researchers, including Lukas Kenner from the Clinical Department of Pathology at MedUni Vienna, has discovered a specific combination of mutations and new gene fusions, which are heavily implicated in tumour growth in patients with a particularly...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?cHash=6a2d709801f85c61eac73d68cbc1a9d3&tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=2862
Detailsite | MedUni Vienna
...All News An international team of researchers, including Lukas Kenner from the Clinical Department of Pathology at MedUni Vienna, has discovered a specific combination of mutations and new gene fusions, which are heavily implicated in tumour growth in patients with a particularly...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/new-treatment-option-for-subtype-of-aggressive-lymphoma/?L=3
Detailsite | MedUni Vienna
... university lecturer Ao. Univ. Prof. Mag. Dr. Wolfgang Mikulits at the Cancer Research Institute and Ao. Univ. Prof. Dr. Lukas Kenner from the Clinical Institute of Pathology at the Medical University of Vienna. "We examined the role of the enzymes using mouse models, and thanks to the cooperation with clinical research groups we were also able to compare the results with human tumour cells." Among those responsible here was the group of Lukas Kenner together with the teratoma specialist Ao. Univ. Prof. Dr. Martin Susani, which observed the same effect in its tests: the more aggressive the human teratoma...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=425&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=d1f88d9a1aff823513d6447df8548700
Detailsite | MedUni Vienna
... university lecturer Ao. Univ. Prof. Mag. Dr. Wolfgang Mikulits at the Cancer Research Institute and Ao. Univ. Prof. Dr. Lukas Kenner from the Clinical Institute of Pathology at the Medical University of Vienna. "We examined the role of the enzymes using mouse models, and thanks to the cooperation with clinical research groups we were also able to compare the results with human tumour cells." Among those responsible here was the group of Lukas Kenner together with the teratoma specialist Ao. Univ. Prof. Dr. Martin Susani, which observed the same effect in its tests: the more aggressive the human teratoma...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?cHash=d1f88d9a1aff823513d6447df8548700&tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=425
Detailsite | MedUni Vienna
... university lecturer Ao. Univ. Prof. Mag. Dr. Wolfgang Mikulits at the Cancer Research Institute and Ao. Univ. Prof. Dr. Lukas Kenner from the Clinical Institute of Pathology at the Medical University of Vienna. "We examined the role of the enzymes using mouse models, and thanks to the cooperation with clinical research groups we were also able to compare the results with human tumour cells." Among those responsible here was the group of Lukas Kenner together with the teratoma specialist Ao. Univ. Prof. Dr. Martin Susani, which observed the same effect in its tests: the more aggressive the human teratoma...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/surprising-enzyme-function-discovered-in-tumour-development/?L=3
Detailsite | MedUni Vienna
...All News Vienna (12th September 2011) – The MedUni Vienna and AKRON Molecules have signed a licence and cooperation agreement for the development of a new therapy with few side effects for a group of rare, malignant tumours in the lymphatic system. Lukas Kenner from the Clinical...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?cHash=af4aca4673bd6a53282ca87e2a84a8df&tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=725
Detailsite | MedUni Vienna
...All News Vienna (12th September 2011) – The MedUni Vienna and AKRON Molecules have signed a licence and cooperation agreement for the development of a new therapy with few side effects for a group of rare, malignant tumours in the lymphatic system. Lukas Kenner from the Clinical...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/?tx_news_pi1%5Bnews%5D=725&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Baction%5D=detail&cHash=af4aca4673bd6a53282ca87e2a84a8df
Detailsite | MedUni Vienna
...All News Vienna (12th September 2011) – The MedUni Vienna and AKRON Molecules have signed a licence and cooperation agreement for the development of a new therapy with few side effects for a group of rare, malignant tumours in the lymphatic system. Lukas Kenner from the Clinical...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/meduni-vienna-and-akron-molecules-cooperate-in-the-fight-against-aggressive-tumours-in-the-lymphatic-system/?L=3
Detailsite | MedUni Vienna
...All News Vienna (12th September 2011) – The MedUni Vienna and AKRON Molecules have signed a licence and cooperation agreement for the development of a new therapy with few side effects for a group of rare, malignant tumours in the lymphatic system. Lukas Kenner from the Clinical...
https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/meduni-wien-und-akron-molecules-kooperieren-im-kampf-gegen-aggressive-tumore-im-lymphatischen-system/?L=3